Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine
about
Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancersThe high spontaneous mutation rate: is it a health risk?Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human diseaseMultiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an updateGain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogoniaThe paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm.Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome.Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.Molecular diagnosis and comprehensive treatment of multiple endocrine neoplasia type 2 in Southeastern ChinesePediatric Medullary Thyroid CarcinomaDistribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancerSpontaneous mutagenesis is enhanced in Apex heterozygous mice.Spontaneous adrenal pheochromocytoma rupture complicated by intraperitoneal hemorrhage and shockMultiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.Reproductive genetics and the aging male.Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study.
P2860
Q24534231-119508B5-6F7E-45B6-AF89-5EB40D255684Q24603867-64F551F3-C317-4CDC-8C13-DAB8B5252A2FQ28259472-70A9D9BA-9EEC-4A26-8E97-032A98907D7EQ33587821-07D4735D-CEFA-4B1C-B7DC-01818242CDC5Q33771007-BBB6EBE7-09DF-452E-864F-6C058818AE32Q33906096-77C8522E-9363-4355-AADE-B0E18CFFFBA2Q33910077-CCD084F9-6B30-4DD9-B507-191F48C8FF1FQ34468665-D967488F-8285-4938-A598-876BDDD79EC1Q35016357-F0814BC8-23C6-4998-A719-2A187FEF6C64Q36715586-E1EA8855-3023-40A8-8032-95A488750CE1Q36722002-EB849E17-CC44-4244-8EE2-0C92AB3A0B2BQ37290956-66DE6E68-E147-4678-BD85-2C9C1BF1CAAAQ37493345-EC826400-8C0B-4A58-9284-86C7566B4A64Q37917851-E329479B-B340-4954-AE4F-2F8E3E82C04CQ39412594-1E3D0B4C-9169-4254-9B8C-C2E748430FE8Q50418347-545B278E-400E-4862-9761-DBDDA129C2FDQ55377929-13BDCAC8-D460-403B-94F4-28C5728B1A1B
P2860
Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@ast
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@en
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@nl
type
label
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@ast
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@en
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@nl
prefLabel
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@ast
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@en
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@nl
P2093
P2860
P1476
Prevalence and parental origin ...... tude des Tumeurs a Calcitonine
@en
P2093
C Thivolet
G M Lenoir
I Schuffenecker
M Schlumberger
P2860
P304
P407
P577
1997-01-01T00:00:00Z